Glycomics Conference | Glycomics Congress | Proteomics Conference | Lipidomics Conference | Glycoscience Conference | Mass Spectrometry Conference | Pharmacogenomics Conference | Genomics Conference | Dubai | UAE | Europe | USA | Middle East

Theme: Advancing & Expanding Glycomics Sector Focused on Developmental Scientific Research

Glycomics 2021

Tentative Program

Renowned Speakers

Boris-Zaslavsky
Cleveland Diagnostics
USA

Mauro-Baron

Italy

Carlos-Eduardo-A-Souza
Cisne University, Brazil
Brazil

Amilcar-Perez-Riverol
Sao Paulo State University Brazil
Brazil

Bjoem-Riefke
Bayer Pharma Germany
Germany

Christina-Scharnagl
Technical University of Munich Germany
Germany

Jill-Barber
University of Manchester UK
UK

Fumio-Hirata
Ritsumeikan University Japan
Japan

Toshiya-Senda
High Energy Accelerator, Japan
Japan

Jianshe Zhang
Changsha University, China
China

Tzu-Ching Meng
Academia Sinica, Taiwan
Taiwan

Petra Fromme
Arizona State University, USA
USA

Charles W. Carter, Jr
University of North Carolina, USA
USA

John-F-Cipollo
Center for Biologics Evaluation and Research-USFDA, USA
USA

Wladek-Minor
University of Virginia, USA
USA

Claudine-S-Bonder
University of South Australia, Australia
Australia

Igor-L-Barsukov
University of Liverpool , UK
UK

Joachim-Krebs
Max Planck Institute for Biophysical Chemistry, Germany
Germany

John-Vakonakis
University of Oxford, UK
UK

Petras-Dzeja
Mayo Clinic, USA
USA

Glycomics 2021

I would like to congratulate Conference Series for organizing Glycomics 2021 conference scheduled on December 08-09, 2021 as webinar with the theme “Advancing & Expanding Glycomics Sector Focused on Developmental Scientific Research.”

We welcome you to join us at Glycomics 2021 where you will make certain to have an important involvement in researchers from around the globe. Liberal reaction and dynamic interest from the Editorial Board Members of meeting related Journals just as from the researchers, scientists and pioneers in the field of Glycomics and Proteomics will make this gathering as one of the best and beneficial events in 2021.

On behalf of the Conference series Ltd, it is our deep pleasure to invite all the Great Scientists, Academicians, young researchers, Professors, Doctors, Business persons, Nurses, Delegates and Students moreover Who are the front line of warriors in this pandemic situation from all over the world to attend the International Conference on Glycomics and Proteomics which will be held on December 08-09, 2021 As webinar. The main theme of the conference is “Advancing & Expanding Glycomics Sector Focused on Developmental Scientific Research.”

Glycomics 2021 shares an insight into the recent research and cutting edge technologies, which gains immense interest with the colossal and exuberant presence of adepts, young and brilliant researchers, Professors, Doctors, and talented student communities and Primary Health Care meeting’s goal is to bring together, a multi-disciplinary group of Scientists and Researchers, Professors, Doctors from all over the world are invited cordially to present and exchange break-through ideas relating to the and Glycomics and Proteomics promotes top level research and to globalize the quality research in general, thus making discussions, presentations more internationally competitive and focusing attention on the recent outstanding breakthroughs in the field of Glycomics and Proteomics, and future trends and needs.

We’re looking forward to an excellent meeting of all dignitaries from different countries all around the world to share innovative ideas and exciting trends in Glycomics and Proteomics Education which will be held on December 08-09, 2021.

Target Audience:

Glycomics Researchers
Nurse Practitioners
Professors, Associate Professors, Assistant Professors
Ph.D. Scholars
Directors, CEO’s of Organizations
Association Presidents, Vice Presidents, and Professionals
Noble laureates in Health Care and Medicine
Pharmaceutical development companies
Research Institutes and members
Graduates and Postgraduates
Medical devices Manufacturing Companies
Training Institutes
Business Entrepreneurs

Prestigious Award for Young Research’s at Glycomics 2021 – “Advancing & Expanding Glycomics Sector Focused on Developmental Scientific Research”

Glycomics 2021 Committee is glad to announce “International Conference on Glycomics and Proteomics” on December 08-09, 2021 focusing on the theme: “Advancing & Expanding Glycomics Sector Focused on Developmental Scientific Research” Glycomics 2021 developments are maintaining their momentum. Glycomics Conference program delves into strategic discussions.

Glycomics 2021 Young Scientist Awards:

Glycomics 2021Committee is intended to honour prestigious award for talented Young researchers, scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Glycomics.

Young Research’s Awards at Glycomics 2021 for the Nomination: Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation, only 25 presentations acceptable at Glycomics 2021 young research forum.

Benefits

Young Scientist Award recongination certificate and memento to the winners.
Our conferences provide best Platform for your research through oral presentations.
Learn about career improvement with all the latest technologies by networking.
Young Scientists will get appropriate and timely information by this Forum.
Platform for collaboration among young researchers for better development.
Provide an opportunity for research interaction and established senior investigators across the globe in the field.
Share the ideas with both eminent researchers and mentors.
It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge.

Eligibility

Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty with a minimum of 5 years of research experience
Presentation must be into scientific sessions of the conference.
Each Young Researcher / Young Scientist can submit only one paper (as first author or co-author).
Age limit-Under 35yrs
All submissions must be in English.

Session 1: Glycomics

Glycomics is a subset of the field of glycobiology that aims to identify the structure and function of the complete set of glycans produced in a given cell or organism and identify all the genes that encode glycoproteins.

Session 2: Proteomics

Proteomics refers to the study of proteomes, but is also used to describe the techniques used to determine the entire set of proteins of an organism or system, such as protein purification and mass spectrometry.

Session 3: Glycosaminoglycans

Polysaccharide side chains of https://glycomics.conferenceseries.com/proteoglycans or free complex polysaccharides composed of linear disaccharide repeating units each composed of a hexosamine and a hexose or a hexuronic acid. See Heparin, Heparan sulfate, Chondroitin sulfate, Dermatan sulfate, and Hyaluronan.

Session 4: Glycoproteomics

Glycoproteomic studying uncovers new clinical glycoprotein biomarkers, which can be used for both disease diagnosis and monitoring and evaluating therapeutic efficiency, and even for personal medicine purpose.

Session 5: Proteomics in Biomedical

The integration of genomic and proteomic data will help to elucidate the functions of proteins in the pathogenesis of diseases and the ageing process, and could lead to the discovery of novel drug target proteins and biomarkers of diseases.

Session 6: Mass Spectrometry

Mass spectrometry (MS) based glycomics techniques are broadly used to analyze free oliogsaccharides, glycosaminoglycans as well as the glycan portions of glycoproteins, proteoglycans and glycolipids. A wide range of MS equipment are available for glycoconjugate analysis.

Session 7: Genomics

A novel approach combining genome-wide association and high-throughput Glycomics analysis of 2,705 individuals in three population cohorts showed that common variants in the Hepatocyte Nuclear Factor 1α (HNF1α) and fucosyltransferase genes FUT6 and FUT8 influence N-glycan levels in human plasma.

Session 8: Clinical Glycomics & Proteomics

Clinical glycomics comprises a spectrum of different analytical methodologies to analyze glycan structures, which provides insights into the mechanisms of glycosylation. Within clinical diagnostics, glycomics serves as a functional readout of genetic variants, and can form a basis for therapy development, as was described for PGM1-CDG

Session 9: Glycoscience

Glycoscience comprises a broad range of knowledge and research on simple and complex carbohydrate metabolism, anabolism, structure, and function. Glycans are expressed in all microorganisms, including prions, as well as in all higher organisms, thus it is not surprising that their biological and disease impacts are profound.

Session 10: Carbohydrates

An alternative definition is the entirety of carbohydrates in a cell. The glycome may in fact be one of the most complex entities in nature. "Glycomics, analogous to genomics and proteomics, is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology

Session 11: Glycomics Profiling

Glycoproteins participate in various biological processes, but glycoproteins analysis is a big challenge because of the low abundance and heterogeneity of glycans. Creative Biolabs has successfully explored a series of innovative glycomic profiling platforms to help our clients identify an entire set of N- and O-glycans with high sensitivity and specificity in the biological material.

Session 12: Glyco-oncology

Glycans in relation to cancer development towards developing clinically useful biomarkers for the early detection of cancer by using a variety of approaches and technologies.

Session 13: Glyco-immunology

The role of nucleic acid and protein variation in human disease, including HIV, the impact of glycosylation changes has been poorly defined. Glycans decorate nearly all proteins in the body, respond rapidly and dramatically to inflammatory cues, and have been centrally implicated in regulating the immune response

Session 14: Genetics and Molecular Biology

Proteomics technologies have produced a profusion of drug targets, which is creating a lock in drug development process. There is an increasing need for better target recognition for new drug development and proteomic technologies which are contributing to it. Identifying a potential protein Mass spectrometry plays a vital role in proteomics and has become an indispensable tool for molecular and cellular biology.

Session 15: Biomedical Applications

Applications of proteomics in the discovery of new diagnostic, prognostic and therapeutic targets cover a wide range of example applications for the most important diseases, such as heart and cardiovascular disorders, cancer, pharm toxicology, infectious diseases and diseases of the nervous system. Unraveling Biological Pathways and the Identification of Clinical Markers Clinical proteomics: early diagnosis Technologies for micro proteomic analysis.

Session 16: Mass Spectrometry Proteomics

Mass determination and Characterization of proteins can be done through Mass Spectrometry. For Ionization of protein in Mass Spectrometry two methods are used such as Electrospray Ionization and matrix-assisted laser desorption/Ionization. Top-down and Bottom-up approaches are used for the analysis of protein. Tandem Mass Spectrometry Targeted Mass Spectrometry Plasma Mass Spectrometry Gas Source Spectrometry Accelerator Spectrometry.

Session 17: Quantitative Proteomics

Quantitative Proteomics is a Scientific Technique which is used to resolve the amount of protein present in a sample which can be further used to compare between diseased and Healthy patients. It also affords information about differences between samples. Through Mass Spectrometry Isotopic labelling of Proteins or Peptides can be Differentiated. The quantitative Proteomic approach is accordant with the increasingly broad-scope analyses which are used in other life science fields such as genomics, kinemics, transcriptomics, and metabolomics. 2DE-DIGE Mass Spectroscopy Quantitative Dot Blot(QDB) Electrospray Ionization Optimizing LC-Ms/MS for Quantitative Proteomics.

Session 18: Pharmacogenomics

Pharmacogenomics is the study of how genes affect a person’s response to drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup. Drug discovery technologies Predictive Prescribing Random Library Screening Limitations of Pharmacogenomics.

Session 19: Cardiovascular Proteomics

Cardiovascular Diseases such as angina and Heart attack which are known as Coronary artery diseases are diagnosed by Proteomics by fulfilling its potential. And many Proteomic techniques are rapidly evolving. The interplay between proteome change and cardiovascular disease can be understood by Biochemical and Physiological methods. Morbidity and Mortality are caused mainly due to Cardiovascular disease which causes deaths. Transcriptome and RNA Profiling is used to outline CVD processes and search for Biomarkers of the disease. DIGE of Rat Heart Proteins Anti-Hypertensive Therapy 2D PAGE for Cardiovascular Proteomics Analyse Cardiac Muscle Proteome.

Session 20: Glycan Biomarkers

Glycan-based biomarkers are currently used for diagnosis of diabetes, cancers, and other complex diseases. We will recapitulate the discovery of glucose, glycated proteins, glycan-, and glycoprotein-based biomarkers followed by summarizing clinically used glycan/glycoprotein-based biomarkers.

The global glycomics market size was estimated at USD 822.5 million in 2018. It is anticipated to expand at a CAGR of 14.7% over the forecast period. Technological advancements are expected to drive the market. Rising investments in research by various government bodies and development of novel drugs by pharmaceutical and biotechnology companies are other major contributing factors. In addition, rising focus on glycomics and proteomics research studies is anticipated to propel market expansion in near future.

Rising investments from governments and organizations have enabled academic researchers to develop new glycomics and glycobiology tools. This factor is anticipated to drive the field of glycoscience, thereby driving the overall market. In glycoproteomics, there is a need for advanced analytical methods for studying pathogen and human glycobiology in disease and health.

Hence, there has been a rise in biomedical and proteomics research, leading to the growth of this market. Technological advancements have also contributed to the increased demand for glycomics instruments. Procedures like protein characterizations are evolving into advanced technologies, such as High Performance Liquid Chromatography (HPLC), Mass Spectrometry (MS), and Capillary Electrophoresis (CE) in chemical and biochemical research. These advanced techniques provide rapid and high-sensitivity results.

Pharmaceutical and biotechnology companies are growing with increasing R&D activities, which include glycomics research. For instance, Thermo Fisher Scientific invested around USD 888 million in R&D in 2017. Agilent Technologies spent USD 339 million on R&D in 2017. Moreover, small-scale pharmaceutical companies are also spending more on R&D. This factor is anticipated to accelerate market growth in the years to come.

Glycomics Market Share Insights

Some of the key companies in the market include Thermo Fisher Scientific, Inc.; Merck KGaA; Agilent Technologies; Bruker; New England Biolabs; Danaher; Shimadzu Corporation; Takara Bio, Inc.; and ProZyme. Majority of these companies have an extensive product portfolio coupled with strong regional presence.

New product launches, mergers and acquisitions, partnerships, and collaborations are the key strategies undertaken by these companies for sustainable growth. For instance, in February 2018, Merck KGaA invested 40 million Euros to enhance their distribution and manufacturing services in the Asian region.

In another instance, in July 2018, Agilent Technologies completed the acquisition of ULTRA Scientific Assets, a company engaged in distribution of certified chemical materials and standards. This acquisition was aimed at providing the company with life sciences solutions, creating a wider consumer base.

Glycomics is a relatively novel technique and research is being conducted on its innovative applications. Therefore, major glycomics market participants are collaborating with academic institutes for the development of newer techniques. For instance, collaboration brought about by Agilent Technologies with the University of Southern California to facilitate researchers in the field of diagnostics, new drug development, and medical devices.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	December 08-09, 2021
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

International Conference on Glycomics and Proteomics December 08-09, 2021 Dubai, UAE

Recommended Global Biochemistry Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Renowned Speakers

Glycomics 2021

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues